{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T18:50:13Z","timestamp":1789671013838,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Merial"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.jconrel.2016.08.012","type":"journal-article","created":{"date-parts":[[2016,8,11]],"date-time":"2016-08-11T21:53:27Z","timestamp":1470952407000},"page":"19-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"special_numbering":"C","title":["Rabies vaccination in dogs using a dissolving microneedle patch"],"prefix":"10.1016","volume":"239","author":[{"given":"Jaya M.","family":"Arya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristopher","family":"Dewitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Scott-Garrard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Wei","family":"Chiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Prausnitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2016.08.012_bb0005","doi-asserted-by":"crossref","unstructured":"S. Plotkin, W. Orenstein, P. Offit, Rabies vaccines, in: Vaccines, Elsevier pp. 687\u2013714, 2008.","DOI":"10.1016\/B978-1-4160-3611-1.50031-3"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0010","doi-asserted-by":"crossref","first-page":"7140","DOI":"10.1016\/j.vaccine.2010.08.082","article-title":"Rabies vaccines: WHO position paper\u2013recommendations","volume":"28","author":"Publication","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0015","first-page":"1","article-title":"WHO Expert Consultation on Rabies","author":"O. World Health","year":"2013"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0020","series-title":"Recommendations and Reports: Morbidity and Mortality Weekly Report. Recommendations and Reports\/Centers for Disease Control","first-page":"1","article-title":"Human rabies prevention\u2013United States, 2008: recommendations of the advisory committee on immunization practices, MMWR","volume":"57","author":"Manning","year":"2008"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0025","series-title":"Rabies in the U.S.","author":"CDC","year":"2011"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0030","unstructured":"WHO, Rabies Factsheet Updated September 2015, (in), http:\/\/www.who.int\/mediacentre\/factsheets\/fs099\/en, (Accessed Jan. 28, 2016)."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0035","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1592\/phco.29.10.1182","article-title":"Overview, prevention, and treatment of rabies","volume":"29","author":"Nigg","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0040","first-page":"693","article-title":"Antibody response of patients after postexposure rabies vaccination with small intradermal doses of purified chick embryo cell vaccine or purified Vero cell rabies vaccine","volume":"78","author":"Briggs","year":"2000","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0045","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1016\/j.vaccine.2006.01.051","article-title":"Revision of the Thai red cross intradermal rabies post-exposure regimen by eliminating the 90-day booster injection","volume":"24","author":"Khawplod","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0050","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.vaccine.2004.09.027","article-title":"Reducing the cost of post-exposure rabies prophylaxis: efficacy of 0.1ml PCEC rabies vaccine administered intradermally using the Thai red cross post-exposure regimen in patients severely exposed to laboratory-confirmed rabid animals","volume":"23","author":"Quiambao","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0055","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1016\/j.vaccine.2012.11.021","article-title":"Intradermal delivery for vaccine dose sparing: overview of current issues","volume":"31","author":"Zehrung","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0060","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri2622","article-title":"Skin immune sentinels in health and disease","volume":"9","author":"Nestle","year":"2009","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0065","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1016\/j.vaccine.2008.03.095","article-title":"Intradermal vaccine delivery: will new delivery systems transform vaccine administration?","volume":"26","author":"Lambert","year":"2008","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0070","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2471\/BLT.10.079426","article-title":"Intradermal delivery of vaccines: potential benefits and current challenges","volume":"89","author":"Hickling","year":"2011","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0075","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1378\/chest.106.5.1463","article-title":"INfluence of needle gauge in mantoux skin testing","volume":"106","author":"Flynn","year":"1994","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0080","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0897-1897(04)00079-5","article-title":"Intradermal injections: traditional bevel up versus bevel down","volume":"17","author":"Tarnow","year":"2004","journal-title":"Appl. Nurs. Res."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0085","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1586\/erv.09.77","article-title":"DNA vaccines in veterinary use","volume":"8","author":"Redding","year":"2009","journal-title":"Expert Rev. Vaccines"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0090","author":"WHO"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0095","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.addr.2012.04.005","article-title":"Microneedles for drug and vaccine delivery","volume":"64","author":"Kim","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0100","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jconrel.2012.01.042","article-title":"Microneedle technologies for (trans)dermal drug and vaccine delivery","volume":"161","author":"van der Maaden","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0105","doi-asserted-by":"crossref","unstructured":"J. Arya, M.R. Prausnitz, Microneedle patches for vaccination in developing countries, J. Control. Release, 2015, http:\/\/dx.doi.org\/10.1016\/j.jconrel.2015.11.019. [Epub ahead of print].","DOI":"10.1016\/j.jconrel.2015.11.019"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4155\/tde.12.13","article-title":"Microneedle delivery: clinical studies and emerging medical applications","volume":"3","author":"Pettis","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0115","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11095-010-0167-x","article-title":"In vivo, in situ imaging of microneedle insertion into the skin of human volunteers using optical coherence tomography","volume":"28","author":"Coulman","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0120","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jconrel.2012.05.030","article-title":"The development and characteristics of novel microneedle arrays fabricated from hyaluronic acid, and their application in the transdermal delivery of insulin","volume":"161","author":"Liu","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0125","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-014-1301-y","article-title":"Hydrogel-forming microneedle arrays can be effectively inserted in skin by self-application: a pilot study centred on pharmacist intervention and a patient information leaflet","author":"Donnelly","year":"2014","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0130","doi-asserted-by":"crossref","first-page":"4659","DOI":"10.1016\/j.vaccine.2015.07.079","article-title":"Cutaneous vaccination - protective immunization is just a skin-deep step away","volume":"33","author":"Teunissen","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0135","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s11095-010-0174-y","article-title":"Transdermal delivery of macromolecules using solid-state biodegradable microstructures","volume":"28","author":"Wendorf","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0140","doi-asserted-by":"crossref","DOI":"10.1016\/j.jconrel.2016.01.027","article-title":"Formulations for Microprojection\/Microneedle Vaccine Delivery: Structure, Strength and Release Profiles","author":"Raphael","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0145","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jconrel.2012.04.001","article-title":"Transcutaneous immunization using a dissolving microneedle array protects against tetanus, diphtheria, malaria, and influenza","volume":"160","author":"Matsuo","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0150","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1073\/pnas.1214449110","article-title":"Langerin negative dendritic cells promote potent CD8(+) T-cell priming by skin delivery of live adenovirus vaccine microneedle arrays","volume":"110","author":"Bachy","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0155","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.jconrel.2012.07.039","article-title":"Microneedle mediated intradermal delivery of adjuvanted recombinant HIV-1 CN54gp140 effectively primes mucosal boost inoculations","volume":"162","author":"Pattani","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0160","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/nm.2182","article-title":"Dissolving polymer microneedle patches for influenza vaccination","volume":"16","author":"Sullivan","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0165","doi-asserted-by":"crossref","first-page":"4683","DOI":"10.1016\/j.vaccine.2015.01.089","article-title":"Inactivated polio vaccination using a microneedle patch is immunogenic in the rhesus macaque","volume":"33","author":"Edens","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0170","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.vaccine.2012.09.062","article-title":"Measles vaccination using a microneedle patch","volume":"31","author":"Edens","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0175","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1016\/j.vaccine.2012.11.027","article-title":"Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch","volume":"31","author":"Moon","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0180","doi-asserted-by":"crossref","first-page":"7968","DOI":"10.1073\/pnas.0812652106","article-title":"Immunization by vaccine-coated microneedle arrays protects against lethal influenza virus challenge","volume":"106","author":"Zhu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0185","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2006.10.017","article-title":"Coated microneedles for transdermal delivery","volume":"117","author":"Gill","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0190","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/gt.2010.22","article-title":"Cutaneous vaccination using microneedles coated with hepatitis C DNA vaccine","volume":"17","author":"Gill","year":"2010","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0195","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.vaccine.2014.01.076","article-title":"Microneedle patches: usability and acceptability for self-vaccination against influenza","volume":"32","author":"Norman","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0200","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1517\/17425247.2012.676038","article-title":"Microneedle-mediated vaccine delivery: harnessing cutaneous immunobiology to improve efficacy","volume":"9","author":"Al-Zahrani","year":"2012","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0067888","article-title":"Dry-coated live viral vector vaccines delivered by Nanopatch Microprojections retain long-term thermostability and induce transgene-specific T cell responses in mice","volume":"8","author":"Pearson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0210","doi-asserted-by":"crossref","first-page":"6154","DOI":"10.1038\/srep06154","article-title":"Microneedle-mediated immunization of an adenovirus-based malaria vaccine enhances antigen-specific antibody immunity and reduces anti-vector responses compared to the intradermal route","volume":"4","author":"Carey","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0215","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1038\/srep06094","article-title":"A protective role of murine langerin(+) cells in immune responses to cutaneous vaccination with microneedle patches","volume":"4","author":"Pulit-Penaloza","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0220","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11095-010-0101-2","article-title":"Microneedles in clinical practice\u2013an exploratory study into the opinions of healthcare professionals and the public","volume":"28","author":"Birchall","year":"2011","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0225","doi-asserted-by":"crossref","DOI":"10.1007\/s11095-013-1092-6","article-title":"Development and clinical study of a self-dissolving microneedle patch for transcutaneous immunization device","author":"Hirobe","year":"2013","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0230","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/jps.24283","article-title":"Development of a thermostable microneedle patch for influenza vaccination","volume":"104","author":"Mistilis","year":"2015","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0235","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.biologicals.2014.05.007","article-title":"Vaccine instability in the cold chain: mechanisms, analysis and formulation strategies","volume":"42","author":"Kumru","year":"2014","journal-title":"Biologicals"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0240","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.jconrel.2010.10.033","article-title":"Separable arrowhead microneedles","volume":"149","author":"Chu","year":"2011","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0245","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1016\/j.vaccine.2012.09.062","article-title":"Measles vaccination using a microneedle patch","volume":"31","author":"Edens","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0250","article-title":"Development of a thermostable microneedle patch for influenza vaccination","author":"Mistilis","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0255","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ejpb.2012.03.010","article-title":"Increased immunogenicity of avian influenza DNA vaccine delivered to the skin using a microneedle patch","volume":"81","author":"Kim","year":"2012","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0260","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/mt.2012.69","article-title":"DNA vaccination in the skin using microneedles improves protection against influenza","volume":"20","author":"Song","year":"2012","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0265","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s10544-013-9799-z","article-title":"Effective transcutaneous immunization against hepatitis B virus by a combined approach of hydrogel patch formulation and microneedle arrays","volume":"15","author":"Guo","year":"2013","journal-title":"Biomed. Microdevices"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0270","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1208\/s12249-010-9391-2","article-title":"Naked plasmid DNA formulation: effect of different disaccharides on stability after lyophilisation","volume":"11","author":"Quaak","year":"2010","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0275","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S1473-3099(04)01222-8","article-title":"Revolutionary vaccine technology breaks the cold chain","volume":"4","author":"Das","year":"2004","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0280","unstructured":"The Cost of a Broken Vaccine Cold Chain Part Two, Financial Cost, in, http:\/\/csafeglobal.com\/the-cost-of-a-broken-vaccine-cold-chain-part-two-financial-cost-1, (Accessed Feb. 25, 2016)."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0285","doi-asserted-by":"crossref","first-page":"4020","DOI":"10.1016\/j.vaccine.2007.02.051","article-title":"Virus neutralizing antibody response in mice and dogs with a bicistronic DNA vaccine encoding rabies virus glycoprotein and canine parvovirus VP2","volume":"25","author":"Patial","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0290","series-title":"WHO Guide for Rabies Pre and Post-exposure Prophylaxis in Human (Updated 2013)","author":"W.H.O.","year":"2014"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0295","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jconrel.2010.07.125","article-title":"Dose sparing enabled by skin immunization with influenza virus-like particle vaccine using microneedles","volume":"147","author":"Quan","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0300","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jconrel.2010.09.001","article-title":"Improved DNA vaccination by skin-targeted delivery using dry-coated densely-packed microprojection arrays","volume":"148","author":"Chen","year":"2010","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0305","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/nrg2432","article-title":"DNA vaccines: ready for prime time?","volume":"9","author":"Kutzler","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0310","series-title":"Temperature sensitivity of vaccines","author":"WHO","year":"2006"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0315","unstructured":"PATH, Summary of stability data for investigational formulations of vaccines, in, 2012."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0320","doi-asserted-by":"crossref","first-page":"5850","DOI":"10.1016\/j.vaccine.2010.06.062","article-title":"Safety and efficacy of novel dermal and epidermal microneedle delivery systems for rabies vaccination in healthy adults","volume":"28","author":"Laurent","year":"2010","journal-title":"Vaccine"},{"key":"10.1016\/j.jconrel.2016.08.012_bb0325","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1093\/ilar.47.4.326","article-title":"Selection, acclimation, training, and preparation of dogs for the research setting","volume":"47","author":"Meunier","year":"2006","journal-title":"ILAR J."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0330","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1089\/dia.2009.0176","article-title":"Pharmacokinetic and pharmacodynamic evaluation of insulin dissolving microneedles in dogs","volume":"12","author":"Fukushima","year":"2010","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0335","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1136\/vr.159.12.379","article-title":"Control of rabies in Jaipur, India, by the sterilisation and vaccination of neighbourhood dogs","volume":"159","author":"Reece","year":"2006","journal-title":"Vet. Rec."},{"key":"10.1016\/j.jconrel.2016.08.012_bb0340","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.prevetmed.2010.07.009","article-title":"Stray dog population demographics in jodhpur, India following a population control\/rabies vaccination program","volume":"97","author":"Totton","year":"2010","journal-title":"Prev. Vet. Med."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916305144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365916305144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T23:31:45Z","timestamp":1600990305000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365916305144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":68,"alternative-id":["S0168365916305144"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.012","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rabies vaccination in dogs using a dissolving microneedle patch","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2016.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}